MONROVIA, CA, August 19, 2009
/24-7PressRelease/ -- Given the high drug attrition rates and the declining number of new chemical entities turned into approved medicines, there exists an urgent need to increase the effectiveness and probability of success of the classical drug discovery process. An alarming statistics in drug development indicate that the average success rate for all therapeutic areas is approximately 11% and only 1 in 9 compounds makes it through development to get approved by the regulatory agencies. There exists an urgent need to increase the effectiveness and probability of success of the pharmaceutical industry by integrating biomarkers in early development. Translational medicine became an essential component of this effort and is one of the largest growing areas of drug discovery and development.
For these reasons the field of Translational Medicine is of continuously escalating significance. The Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference will be held October 14-16, 2009 in San Diego, CA. The conference covers a wide range of topics in the field, from the new technologies facilitating biomarker discovery and the identification of safety biomarkers used to measure toxicity in vital organs, to the development of more predictive pre-clinical models and the discussion of partnering opportunities in translational medicine. This conference offers scientists, clinicians, medical practitioners and specialists, students, R&D experts and patients the opportunity to meet and discuss the latest breakthroughs and advances in the field of biomarkers and translational medicine.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
- biotech, clinical, conferences, epimiology, evidence-based, gtcbio, interventional, medicine, research, translational, trials
Read more Press Releases from Rania Hafez:- Joost Oppenheim, M.D., Laboratory Chief - NCI, to give Keynote Presentation at GTCbio's 8th Cytokines & Inflammation Conference on January 28-29, 2010 in San Diego, CA
- Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
- Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
- Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio on October 14-16, 2009 in San Diego, CA.
- GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009.
- Dr. Joseph Bolen, CSO of Millennium to give Keynote Presentation at GTCbio's 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, MA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
- Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio's Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
- Alison Goss Eng of US Dept. of Energy to Present at GTCbio's Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 29-30, 2009 in San Francisco, CA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
Other Press Release Headlines:
